Axial Biotech, Inc. was a privately held molecular diagnostics company based in Salt Lake City, Utah. It was founded in 2002. The company's mission was to deliver diagnostics that improve and personalize the treatment of spine disorders. Axial Biotech conducted genetic research on scoliosis and degenerative disc disease. In September 2009, Axial Biotech announced the commercial launch of the ScoliScore AIS Prognostic Test with the claim of it being a DNA-based diagnostic test for scoliosis. In 2012 acquired the rights to the ScoliScore test.